Research programme: nanoparticle-based cancer vaccines - Therapeutics Solutions InternationalAlternative Names: Exosomes - Therapeutics Solutions International
Latest Information Update: 30 Dec 2015
At a glance
- Originator Institute for Molecular Medicine; John Wayne Cancer Institute; Therapeutics Solutions International
- Class Antineoplastics
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Cancer
Most Recent Events
- 23 Nov 2015 Early research in Cancer in USA (unspecified route)
- 23 Nov 2015 Therapeutics Solutions International has patents pending for nanoparticle-based cancer vaccines in US